Curtis Cooper
Senior Scientist, Inflammation and Chronic Disease
Ottawa Hospital Research Institute
Professor, Deptartment of Medicine
University of Ottawa
Head, Division of Infectious Diseases
The Ottawa Hospital
Research Interests
Brief Biography
Curtis Cooper trained at the University of Saskatchewan (MD 1994). He received certification in Internal Medicine in 1997 and in Infectious Diseases in 1999 while at the University of Manitoba. He completed an HIV Research Fellowship and Masters of Epidemiology in 2002 while at the University of Ottawa. He is currently a Professor with the University of Ottawa, Infectious Diseases Consultant with The Ottawa Hospital Division of Infectious Diseases, Scientist with the Ottawa Health Research Institute, Director of The Ottawa Hospital Viral Hepatitis Program. As a clinical researcher, his research activities encompass viral hepatitis, HIV and vaccine development. His work is focused on the development of new therapeutic agents and the delivery of treatments that maximizes safety, adherence and effectiveness. He also oversees cohort research related to HBV, HCV, HIV and COVID19.
Selected Publications
Keeshan A, Galipeau Y, Heiskanen A, Collins E, McCluskie PS, Arnold C, Saginur R, Booth R, Little J, McGuinty M, Buchan CA, Crawley A, Langlois MA, Cooper C. Results of the Stop the Spread Ottawa (SSO) cohort study: a Canadian urban-based prospective evaluation of antibody responses and neutralisation efficiency to SARS-CoV-2 infection and vaccination. BMJ Open. 2023;13(10):e077714.
Petrosyan Y, Simmons JG, Kelly E, Cooper CL. Uptake and factors associated with direct-acting antiviral therapy for hepatitis C and treatment outcomes among Canadian immigrants: A retrospective cohort analysis. Can Liver J. 2022;5(3):388-401.
Angel M, Petrosyan Y, Doyle MA, Cooper C. HCV infection characteristics, treatment uptake and outcomes in patient with diabetes mellitus. BMC Endocr Disord. 2022;22(1):277
Rana U, Driedger M, Sereda P, Pan S, Ding E, Wong A, Walmsley S, Klein M, Kelly D, Loutfy M, Thomas R, Sanche S, Kroch A, Machouf N, Roy-Gagnon MH, Hogg B, Cooper C, for the Canadian Observation Cohort (CANOC) Collaboration. Clinical and demographic predictors of antiretroviral efficacy in HIV–HBV co-infected patients. JAMMI. 2021;6(2):137-48
Cooper C, Driedger M, Wong D, Haylock-Jacobs S, Aziz Shaheen A, Osiowy C, Fung S, Doucette K, Wong A, Barrett L, Conway B, Ramji A, Minuk G, Sebastiani G, Wong P, Coffin CS. Distinct Hepatitis B and HIV co-infected populations in Canada. J Viral Hepat. 2021;28(3):517-27.
Diseases, conditions and populations of interest
Research and clinical approaches
